PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 148 filers reported holding PDL BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $174,000 | -66.6% | 55,500 | -63.9% | 0.00% | -60.0% |
| Q3 2017 | $521,000 | +37.5% | 153,600 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $379,000 | -16.7% | 153,600 | -23.4% | 0.00% | 0.0% |
| Q1 2017 | $455,000 | -25.4% | 200,400 | +10.0% | 0.00% | -33.3% |
| Q3 2016 | $610,000 | – | 182,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |